Application of multiprobe fluorescence in situ hybridization panel in the diagnosis of acute myeloid leukemia
OBJECTIVE: To assess the value of multiprobe fluorescence in situ hybridization (FISH) panel in the diagnosis of acute myeloid leukemia (AML).
METHODS: The multiprobe AML/MDS panel comprising 8 different FISH probes for AML1/ETO transfusion gene, PML-RARα transfusion gene, CBFβ/MYH11 transfusion gene, MLL breakapart, P53 deletion, Del(5q), -7/Del(7q), and Del(20q) was tested in 40 cases of AML, and the results were compared with those by conventional cytogenetic G-banding (CCG) test.
RESULTS: With multiprobe FISH panel, 22 of the 40 AML cases were found to carry 7 types of cytogenetic abnormalities, namely AML1/ETO transfusion gene, PML-RARα transfusion gene, MLL breakapart, P53 deletion, Del(5q), -7/Del(7q) and trisomy 8. The positive ratio of the multiprobe FISH was 57.5%. CCG only identified 8 cases with the corresponding cytogenetic abnormalities and 3 cases with other cytogenetic abnormalities, and the positive ratio was only 27.50%.
CONCLUSION: Mutiprobe FISH panel is more rapid, accurate and effective than CCG in the diagnosis of AML.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2011 |
---|---|
Erschienen: |
2011 |
Enthalten in: |
Zur Gesamtaufnahme - volume:31 |
---|---|
Enthalten in: |
Nan fang yi ke da xue xue bao = Journal of Southern Medical University - 31(2011), 7 vom: 28. Juni, Seite 1204-6 |
Sprache: |
Chinesisch |
---|
Beteiligte Personen: |
Xu, Lu-Lu [VerfasserIn] |
---|
Themen: |
Comparative Study |
---|
Anmerkungen: |
Date Completed 16.04.2013 Date Revised 18.07.2011 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM21000682X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM21000682X | ||
003 | DE-627 | ||
005 | 20231224010830.0 | ||
007 | tu | ||
008 | 231224s2011 xx ||||| 00| ||chi c | ||
028 | 5 | 2 | |a pubmed24n0700.xml |
035 | |a (DE-627)NLM21000682X | ||
035 | |a (NLM)21764696 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a chi | ||
100 | 1 | |a Xu, Lu-Lu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Application of multiprobe fluorescence in situ hybridization panel in the diagnosis of acute myeloid leukemia |
264 | 1 | |c 2011 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 16.04.2013 | ||
500 | |a Date Revised 18.07.2011 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: To assess the value of multiprobe fluorescence in situ hybridization (FISH) panel in the diagnosis of acute myeloid leukemia (AML) | ||
520 | |a METHODS: The multiprobe AML/MDS panel comprising 8 different FISH probes for AML1/ETO transfusion gene, PML-RARα transfusion gene, CBFβ/MYH11 transfusion gene, MLL breakapart, P53 deletion, Del(5q), -7/Del(7q), and Del(20q) was tested in 40 cases of AML, and the results were compared with those by conventional cytogenetic G-banding (CCG) test | ||
520 | |a RESULTS: With multiprobe FISH panel, 22 of the 40 AML cases were found to carry 7 types of cytogenetic abnormalities, namely AML1/ETO transfusion gene, PML-RARα transfusion gene, MLL breakapart, P53 deletion, Del(5q), -7/Del(7q) and trisomy 8. The positive ratio of the multiprobe FISH was 57.5%. CCG only identified 8 cases with the corresponding cytogenetic abnormalities and 3 cases with other cytogenetic abnormalities, and the positive ratio was only 27.50% | ||
520 | |a CONCLUSION: Mutiprobe FISH panel is more rapid, accurate and effective than CCG in the diagnosis of AML | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a DNA Probes |2 NLM | |
700 | 1 | |a Liu, Xiao-Li |e verfasserin |4 aut | |
700 | 1 | |a DU, Qing-Feng |e verfasserin |4 aut | |
700 | 1 | |a Song, Lan-Lin |e verfasserin |4 aut | |
700 | 1 | |a Cao, Rui |e verfasserin |4 aut | |
700 | 1 | |a Xu, Na |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Jin-Fang |e verfasserin |4 aut | |
700 | 1 | |a Huang, Bin-Tao |e verfasserin |4 aut | |
700 | 1 | |a Luo, Xu-Jing |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nan fang yi ke da xue xue bao = Journal of Southern Medical University |d 2006 |g 31(2011), 7 vom: 28. Juni, Seite 1204-6 |w (DE-627)NLM16087646X |x 1673-4254 |7 nnns |
773 | 1 | 8 | |g volume:31 |g year:2011 |g number:7 |g day:28 |g month:06 |g pages:1204-6 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 31 |j 2011 |e 7 |b 28 |c 06 |h 1204-6 |